Oral Administration of Anti-CD3 Monoclonal Antibody in Non-responder Genotype-I Chronic Hepatitis C Subjects
Phase 2
- Conditions
- Chronic Hepatitis C
- Interventions
- Drug: Sodium Chloride placebo
- First Posted Date
- 2011-10-25
- Last Posted Date
- 2011-10-25
- Lead Sponsor
- Inspira Medical AB
- Target Recruit Count
- 36
- Registration Number
- NCT01459419
- Locations
- 🇦🇹
Univ.Klinik für Innere Medizin IV, Wien, Austria
🇵🇱Katedra i Klinika Chorób Zakaźnych i Hepatologii Wojewódzki Szpital Obserwacyjno - Zakaźny im. Tadeusza Browicza, Bydgoszcz, Poland
© Copyright 2025. All Rights Reserved by MedPath